Cystatin C and Cognitive Impairment 10 Years Later in Older Women

Yelena Slinin, Katherine W. Peters, Areef Ishani, Kristine Yaffe, Howard A. Fink, Katie L. Stone, Michael Steffes, Kristine E. Ensrud, for the Study of Osteoporotic Fractures

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background. Results of prospective studies examining the association between cystatin C and incident cognitive impairment have been inconsistent. We tested the hypothesis that there is a U-shaped association in older women between cystatin C and risk of incident cognitive impairment 10 years later. Methods. We conducted a longitudinal analysis of a prospective cohort of 1,332 communitydwelling elderly women without dementia at baseline who had baseline cystatin C and serum creatinine measurements and completed an extended cognitive battery of neuropsychological tests with determination of cognitive status 10 years later. Incident cognitive impairment was defined as either new onset of adjudicated diagnosis of mild cognitive impairment or dementia. Results. Incident mild cognitive impairment or dementia was identified among 140 (26.0%) women in quartile 1 (Q1), 122 (22.6%) in Q2, 121 (22.5%) in Q3, and 156 (28.9%) in Q4 of cystatin C. In the fully adjusted model, compared to women in Q2-Q3 of cystatin C, adjusted odds ratios (95% CI) for incident cognitive impairment were 1.31 (0.98-1.75) for Q1, and 1.25 (0.94-1.66) for Q4 Compared to women in Q2-Q3 of estimated glomerular filtration rate (EGFRCysC), adjusted odds ratios (95% CI) for incident cognitive impairment after 10 years of follow-up were 1.18 (0.88-1.58) for Q4 (EGFRCysC 76.1-109.4 mL/min/1.73 m2) and 1.26 (0.94-1.67) for Q1 (EGFRCysC 21.8-55.5 mL/min/1.73 m2). Conclusions. These results support a U-shaped association between cystatin C concentration and risk of cognitive impairment or dementia 10 years later, but the association is not independent of potential confounding factors.

Original languageEnglish (US)
Pages (from-to)771-778
Number of pages8
JournalJournals of Gerontology - Series A Biological Sciences and Medical Sciences
Volume70
Issue number6
DOIs
StatePublished - Jan 1 2015

Fingerprint

Cystatin C
Dementia
Odds Ratio
Cognitive Dysfunction
Neuropsychological Tests
Glomerular Filtration Rate
Creatinine
Prospective Studies

Keywords

  • Aging
  • Cognitive impairment
  • Cystatin C

Cite this

Cystatin C and Cognitive Impairment 10 Years Later in Older Women. / Slinin, Yelena; Peters, Katherine W.; Ishani, Areef; Yaffe, Kristine; Fink, Howard A.; Stone, Katie L.; Steffes, Michael; Ensrud, Kristine E.; for the Study of Osteoporotic Fractures.

In: Journals of Gerontology - Series A Biological Sciences and Medical Sciences, Vol. 70, No. 6, 01.01.2015, p. 771-778.

Research output: Contribution to journalArticle

Slinin, Yelena ; Peters, Katherine W. ; Ishani, Areef ; Yaffe, Kristine ; Fink, Howard A. ; Stone, Katie L. ; Steffes, Michael ; Ensrud, Kristine E. ; for the Study of Osteoporotic Fractures. / Cystatin C and Cognitive Impairment 10 Years Later in Older Women. In: Journals of Gerontology - Series A Biological Sciences and Medical Sciences. 2015 ; Vol. 70, No. 6. pp. 771-778.
@article{1e789fcb20b94e209fb6d558c8c4a190,
title = "Cystatin C and Cognitive Impairment 10 Years Later in Older Women",
abstract = "Background. Results of prospective studies examining the association between cystatin C and incident cognitive impairment have been inconsistent. We tested the hypothesis that there is a U-shaped association in older women between cystatin C and risk of incident cognitive impairment 10 years later. Methods. We conducted a longitudinal analysis of a prospective cohort of 1,332 communitydwelling elderly women without dementia at baseline who had baseline cystatin C and serum creatinine measurements and completed an extended cognitive battery of neuropsychological tests with determination of cognitive status 10 years later. Incident cognitive impairment was defined as either new onset of adjudicated diagnosis of mild cognitive impairment or dementia. Results. Incident mild cognitive impairment or dementia was identified among 140 (26.0{\%}) women in quartile 1 (Q1), 122 (22.6{\%}) in Q2, 121 (22.5{\%}) in Q3, and 156 (28.9{\%}) in Q4 of cystatin C. In the fully adjusted model, compared to women in Q2-Q3 of cystatin C, adjusted odds ratios (95{\%} CI) for incident cognitive impairment were 1.31 (0.98-1.75) for Q1, and 1.25 (0.94-1.66) for Q4 Compared to women in Q2-Q3 of estimated glomerular filtration rate (EGFRCysC), adjusted odds ratios (95{\%} CI) for incident cognitive impairment after 10 years of follow-up were 1.18 (0.88-1.58) for Q4 (EGFRCysC 76.1-109.4 mL/min/1.73 m2) and 1.26 (0.94-1.67) for Q1 (EGFRCysC 21.8-55.5 mL/min/1.73 m2). Conclusions. These results support a U-shaped association between cystatin C concentration and risk of cognitive impairment or dementia 10 years later, but the association is not independent of potential confounding factors.",
keywords = "Aging, Cognitive impairment, Cystatin C",
author = "Yelena Slinin and Peters, {Katherine W.} and Areef Ishani and Kristine Yaffe and Fink, {Howard A.} and Stone, {Katie L.} and Michael Steffes and Ensrud, {Kristine E.} and {for the Study of Osteoporotic Fractures}",
year = "2015",
month = "1",
day = "1",
doi = "10.1093/gerona/glu189",
language = "English (US)",
volume = "70",
pages = "771--778",
journal = "Journals of Gerontology - Series A Biological Sciences and Medical Sciences",
issn = "1079-5006",
publisher = "Oxford University Press",
number = "6",

}

TY - JOUR

T1 - Cystatin C and Cognitive Impairment 10 Years Later in Older Women

AU - Slinin, Yelena

AU - Peters, Katherine W.

AU - Ishani, Areef

AU - Yaffe, Kristine

AU - Fink, Howard A.

AU - Stone, Katie L.

AU - Steffes, Michael

AU - Ensrud, Kristine E.

AU - for the Study of Osteoporotic Fractures

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Background. Results of prospective studies examining the association between cystatin C and incident cognitive impairment have been inconsistent. We tested the hypothesis that there is a U-shaped association in older women between cystatin C and risk of incident cognitive impairment 10 years later. Methods. We conducted a longitudinal analysis of a prospective cohort of 1,332 communitydwelling elderly women without dementia at baseline who had baseline cystatin C and serum creatinine measurements and completed an extended cognitive battery of neuropsychological tests with determination of cognitive status 10 years later. Incident cognitive impairment was defined as either new onset of adjudicated diagnosis of mild cognitive impairment or dementia. Results. Incident mild cognitive impairment or dementia was identified among 140 (26.0%) women in quartile 1 (Q1), 122 (22.6%) in Q2, 121 (22.5%) in Q3, and 156 (28.9%) in Q4 of cystatin C. In the fully adjusted model, compared to women in Q2-Q3 of cystatin C, adjusted odds ratios (95% CI) for incident cognitive impairment were 1.31 (0.98-1.75) for Q1, and 1.25 (0.94-1.66) for Q4 Compared to women in Q2-Q3 of estimated glomerular filtration rate (EGFRCysC), adjusted odds ratios (95% CI) for incident cognitive impairment after 10 years of follow-up were 1.18 (0.88-1.58) for Q4 (EGFRCysC 76.1-109.4 mL/min/1.73 m2) and 1.26 (0.94-1.67) for Q1 (EGFRCysC 21.8-55.5 mL/min/1.73 m2). Conclusions. These results support a U-shaped association between cystatin C concentration and risk of cognitive impairment or dementia 10 years later, but the association is not independent of potential confounding factors.

AB - Background. Results of prospective studies examining the association between cystatin C and incident cognitive impairment have been inconsistent. We tested the hypothesis that there is a U-shaped association in older women between cystatin C and risk of incident cognitive impairment 10 years later. Methods. We conducted a longitudinal analysis of a prospective cohort of 1,332 communitydwelling elderly women without dementia at baseline who had baseline cystatin C and serum creatinine measurements and completed an extended cognitive battery of neuropsychological tests with determination of cognitive status 10 years later. Incident cognitive impairment was defined as either new onset of adjudicated diagnosis of mild cognitive impairment or dementia. Results. Incident mild cognitive impairment or dementia was identified among 140 (26.0%) women in quartile 1 (Q1), 122 (22.6%) in Q2, 121 (22.5%) in Q3, and 156 (28.9%) in Q4 of cystatin C. In the fully adjusted model, compared to women in Q2-Q3 of cystatin C, adjusted odds ratios (95% CI) for incident cognitive impairment were 1.31 (0.98-1.75) for Q1, and 1.25 (0.94-1.66) for Q4 Compared to women in Q2-Q3 of estimated glomerular filtration rate (EGFRCysC), adjusted odds ratios (95% CI) for incident cognitive impairment after 10 years of follow-up were 1.18 (0.88-1.58) for Q4 (EGFRCysC 76.1-109.4 mL/min/1.73 m2) and 1.26 (0.94-1.67) for Q1 (EGFRCysC 21.8-55.5 mL/min/1.73 m2). Conclusions. These results support a U-shaped association between cystatin C concentration and risk of cognitive impairment or dementia 10 years later, but the association is not independent of potential confounding factors.

KW - Aging

KW - Cognitive impairment

KW - Cystatin C

UR - http://www.scopus.com/inward/record.url?scp=84954154842&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84954154842&partnerID=8YFLogxK

U2 - 10.1093/gerona/glu189

DO - 10.1093/gerona/glu189

M3 - Article

VL - 70

SP - 771

EP - 778

JO - Journals of Gerontology - Series A Biological Sciences and Medical Sciences

JF - Journals of Gerontology - Series A Biological Sciences and Medical Sciences

SN - 1079-5006

IS - 6

ER -